|
1
|
Zhang HL, Li JS, Yu XQ, Li SY, Halmurat U,
Xie Y, Wang YF, Li FS and Wang MH: An evaluation of activity
tolerance, patient-reported outcomes and satisfaction with the
effectiveness of pulmonary daoyin on patients with chronic
obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis.
12:2333–2342. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang C, Ding H, Tang X, Li Z and Gan L:
Effect of Liuweibuqi capsules on the balance between MMP-9 and
TIMP1 and viability of alveolar macrophages in COPD. Biosci Rep.
37:53–80. 2017. View Article : Google Scholar
|
|
3
|
Zhuan B, Yu Y, Yang Z, Zhao X and Li P:
Mechanisms of oxidative stress effects of the NADPH
oxidase-ROS-NF-κB transduction pathway and VPO1 on patients with
chronic obstructive pulmonary disease combined with pulmonary
hypertension. Eur Rev Med Pharmacol Sci. 21:3459–3464.
2017.PubMed/NCBI
|
|
4
|
Song S, Yang PS, Kim TH, Uhm JS, Pak HN,
Lee MH and Joung B: Relation of chronic obstructive pulmonary
disease to cardiovascular disease in the general population. Am J
Cardiol. 120:1399–1404. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Donovan LM, Rise PJ, Carson SS, Feemster
LC, Griffith MF, Kapur VK, Krishnan JA, Lindenauer PK, Mularski RA,
Naureckas ET, et al: Sleep disturbance in smokers with preserved
pulmonary function and with chronic obstructive pulmonary disease.
Ann Am Thorac Soc. 14:1836–1843. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Einarsson GG, Comer DM, McIlreavey L,
Parkhill J, Ennis M, Tunney MM and Elborn JS: Community dynamics
and the lower airway microbiota in stable chronic obstructive
pulmonary disease, smokers and healthy non-smokers. Thorax.
71:795–803. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Górka K, Soja J, Jakieła B, Plutecka H,
Gross-Sondej I, Ćmiel A, Mikrut S, Łoboda P, Andrychiewicz A, Jurek
P, et al: Relationship between the thickness of bronchial wall
layers, emphysema score, and markers of remodeling in
bronchoalveolar lavage fluid in patients with chronic obstructive
pulmonary disease. Pol Arch Med Wewn. 126:402–410. 2016.PubMed/NCBI
|
|
8
|
Wendt CH, Nelsestuen G, Harvey S, Gulcev
M, Stone M and Reilly C: Peptides in bronchoalveolar lavage in
chronic obstructive pulmonary disease. PLoS One. 11:e01557242016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Agarwal D, Dhotre D, Patil R, Shouche Y,
Juvekar S and Salvi S: Potential of health and demographic
surveillance system in asthma and chronic obstructive pulmonary
disease microbiome research. Front Public Health. 5:1962017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spathis D and Vlamos P: Diagnosing asthma
and chronic obstructive pulmonary disease with machine learning.
Health Informatics J: 1460458217723169. 2017.(Epub ahead of print).
View Article : Google Scholar
|
|
11
|
Fortún J, Martín-Dávila P, Gomez Garcia de
la Pedrosa E, Silva JT, Garcia-Rodríguez J, Benito D, Venanzi E,
Castaño F, Fernández-Ruiz M, Lazaro F, et al: Galactomannan in
bronchoalveolar lavage fluid for diagnosis of invasive
aspergillosis in non-hematological patients. J Infect. 72:738–744.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gasiuniene E, Lavinskiene S, Sakalauskas R
and Sitkauskiene B: Levels of IL-32 in serum, induced sputum
supernatant, and bronchial lavage fluid of patients with chronic
obstructive pulmonary disease. COPD. 13:569–575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Braeken DC, Rohde GG, Franssen FM,
Driessen JH, van Staa TP, Souverein PC, Wouters EF and de Vries F:
Risk of community-acquired pneumonia in chronic obstructive
pulmonary disease stratified by smoking status: A population-based
cohort study in the United Kingdom. Int J Chron Obstruct Pulmon
Dis. 12:2425–2432. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin CS, Liu CC, Yeh CC, Chang YC, Chung CL
and Lane HL: Diabetes risks and outcomes in chronic obstructive
pulmonary disease patients: Two nationwide population-based
retrospective cohort studies. Int J Chron Obstruct Pulmon Dis.
1:102–110. 2016.
|
|
15
|
Shu J, Lu W, Li D, Liang Z, Xu X, Zhang B
and Wang J: Nose-only cigarette smoke exposure plus airway
lipopolysaccharide inhalation induced chronic obstructive pulmonary
disease and associated pulmonary hypertension in mice. Zhonghua Jie
He He Hu Xi Za Zhi. 38:907–911. 2015.(In Chinese). PubMed/NCBI
|
|
16
|
Giannakaki S, Politi L, Antonogiannaki EM,
Spanakis N, Arsenis G, Filaditaki V, Zakynthinos S, Karagiannidis N
and Tsakris A: Absence of human rhinovirus and respiratory
syncytial virus from bronchoalveolar lavage and bronchial biopsies
of selected patients with stable chronic obstructive pulmonary
disease. Respir Res. 27:112016. View Article : Google Scholar
|
|
17
|
Barnawi J, Tran H, Jersmann H, Pitson S,
Roscioli E, Hodge G, Meech R, Haberberger R and Hodge S: Potential
link between the sphingosine-1-phosphate (S1P) system and defective
alveolar macrophage phagocytic function in chronic obstructive
pulmonary disease (COPD). PLoS One. 10:e01227712015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee B, Ko E, Lee J, Jo Y, Hwang H, Goh TS,
Joo M and Hong C: Soluble common gamma chain exacerbates COPD
progress through the regulation of inflammatory T cell response in
mice. Int J Chron Obstruct Pulmon Dis. 22:817–827. 2017. View Article : Google Scholar
|
|
19
|
Olloquequi J and Silva OR: Biomass smoke
as a risk factor for chronic obstructive pulmonary disease: Effects
on innate immunity. Innate Immun. 22:373–381. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Szpechcinski A, Chorostowska-Wynimko J,
Struniawski R, Kupis W, Rudzinski P, Langfort R, Puscinska E,
Bielen P, Sliwinski P and Orlowski T: Cell-free DNA levels in
plasma of patients with non-small-cell lung cancer and inflammatory
lung disease. Br J Cancer. 113:476–483. 2015. View Article : Google Scholar : PubMed/NCBI
|
